Abstract
Background: In Turner syndrome (TS), fluorescent in situ hybridization (FISH) karyotyping offers an alternative to classical karyotyping. Objective: We tested the added value of FISH karyotyping from lymphocytes (mesodermal origin), buccal cells (ectodermal origin), and a rear-tongue smear (endodermal origin) to determine the 45,X cell line fraction and its impact on patient phenotype. Design and Patients: Classical karyotyping and three FISH assays were done in 153 girls and women previously diagnosed with TS in four university hospitals. The 45,X cell line fraction was determined for each method and correlated with the major phenotypic signs. Results: Classical karyotyping identified 45,X/46,XX mosaicism in 77/153 subjects (50%), 45,X monosomy in 52/153 (34%), and other karyotypes in 24/153 (16%). FISH from lymphocytes verified 45,X in 47/52 original cases, whereas 4/52 had 45,X/46,XX and 1/52 45,X/47,XYY mosaicism. The 45,X cell line fraction was higher in FISH from lymphocytes compared to classical karyotyping (median 86.4% vs. 70.0%; p < 0.001), while there was no difference for FISH from buccal or rear-tongue smear cells. The mean 45,X cell line fraction was more abundant in patients with several of the characteristic phenotypic signs compared to patients without them (p < 0.01), but the predictive power was insufficient. Conclusion: FISH analysis confirmed the findings of classical karyotyping; only a few 45,X monosomy cases were reclassified as mosaics. The 45,X cell line fraction did not show clinically meaningful prediction of the phenotype. FISH analysis of buccal or rear-tongue epithelial cells may be a non-inferior, less invasive alternative to classical karyotyping.
References
1.
Stochholm
K
, Juul
S
, Juel
K
, Naeraa
RW
, Højbjerg Gravholt
C
. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome
. J Clin Endocrinol Metab
. 2006 Oct
;91
(10
):3897
–902
. .2.
Bondy
CA
. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group
. J Clin Endocrinol Metab
. 2007 Jan
;92
(1
):10
–25
. .3.
Gravholt
CH
. Clinical practice in Turner syndrome
. Nat Clin Pract Endocrinol Metab
. 2005 Nov
;1
:41
–52
. .4.
Mortensen
KH
, Andersen
NH
, Gravholt
CH
. Cardiovascular phenotype in Turner syndrome-integrating cardiology, genetics, and endocrinology
. Endocr Rev
. 2012 Oct
;33
(5
):677
–714
. .5.
Schoemaker
MJ
, Swerdlow
AJ
, Higgins
CD
, Wright
AF
, Jacobs
PA
. Mortality in women with turner syndrome in great britain: a national cohort study
. J Clin Endocrinol Metab
. 2008 Dec
;93
(12
):4735
–42
. .6.
Wolff
DJ
, Van Dyke
DL
, Powell
CM
; Working Group of the ACMG Laboratory Assurance Committee
. Laboratory guideline for Turner syndrome
. Genet Med
. 2010 Jan
;12
(1
):52
–5
. .7.
Saenger
P
, Wikland
KA
, Conway
GS
, Davenport
M
, Gravholt
CH
, Hintz
R
, Recommendations for the diagnosis and management of Turner syndrome
. J Clin Endocrinol Metab
. 2001 Jul
;86
(7
):3061
–9
. .8.
Bondy
C
. Recent developments in diagnosis and care for girls in Turner syndrome
. Adv Endocrinol
. 2014
;2014
:1
–9
. .9.
Wiktor
AE
, Van Dyke
DL
. Detection of low level sex chromosome mosaicism in Ullrich-Turner syndrome patients
. Am J Med Genet
. 2005 Sep
;138A
(3
):259
–61
. .10.
Cameron-Pimblett
A
, La Rosa
C
, King
TFJ
, Davies
MC
, Conway
GS
. The Turner syndrome life course project: karyotype-phenotype analyses across the lifespan
. Clin Endocrinol
. 2017 Jun
;87
(5
):532
–8
. .11.
Gravholt
CH
, Andersen
NH
, Conway
GS
, Dekkers
OM
, Geffner
ME
, Klein
KO
, Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
. Eur J Endocrinol
. 2017 Sep
;177
(3
):G1
–70
. .12.
Klaskova
E
, Tüdös
Z
, Sobek
A
, Zapletalová
J
, Dostál
J
, Zbořilová
B
, Low-level 45, X/46, XX mosaicism is not associated with congenital heart disease and thoracic aorta dilatation:prospective magnetic resonance imaging and ultrasound study
. Ultrasound Obstet Gynecol
. 2015 Jul
;45
(6
):722
–7
. .13.
El-Mansoury
M
, Barrenäs
ML
, Bryman
I
, Hanson
C
, Larsson
C
, Wilhelmsen
L
, Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome
. Clin Endocrinol
. 2007 Mar
;66
(5
):744
–51
. .14.
Prandstraller
D
, Mazzanti
L
, Giardini
A
, Lovato
L
, Tamburrino
F
, Scarano
E
, Correlations of phenotype and genotype in relation to morphologic remodelling of the aortic root in patients with Turner’s syndrome
. Cardiol Young
. 2009 Apr
;19
(03
):264
. .15.
Miguel-Neto
J
, Carvalho
AB
, Marques-de-Faria
AP
, Guerra-Júnior
G
, Maciel-Guerra
AT
. New approach to phenotypic variability and karyotype-phenotype correlation in Turner syndrome
. J Pediatr Endocrinol Metab
. 2016 Jan
;29
(4
):475
–9
. .16.
Thunstrom
S
, Landin-Wilhelmsen
K
, Bryman
I
, Hanson
C
. Side differences in the degree of mosaicism of the buccal mucosa in Turner syndrome
. Mol Genet Genomic Med
. 2019 Aug
;7
(10
):e00938
. .17.
Graff
A
, Donadille
B
, Morel
H
, Villy
MC
, Bourcigaux
N
, Vatier
C
, Added value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome
. Hum Reprod
. 2020 Aug
;35
(10
):2391
–8
. .18.
Soares
JS
, da Silva Lago
RMR
, Toralles
MBP
, Mota
LR
, Alves
ES
, de Carvalho
AFL
. Searching chromosome mosaicisms in 45, X Turner syndrome: how relevant is it?
Arch Endocrinol Metab
. 2021 Nov
;65
(6
):739
–46
.19.
Youssoufian
H
, Pyeritz
RE
. Mechanisms and consequences of somatic mosaicism in humans
. Nat Rev Genet
. 2002 Oct
;3
(10
):748
–58
. .20.
Cacciari
E
, Masi
M
, Fantini
MP
, Licastro
F
, Cicognani
A
, Pirazzoli
P
, Serum immunoglobulins and lymphocyte subpopulations derangement in Turner's syndrome
. J Immunogenet
. 1981 Oct
;8
(5
):337
–44
. .21.
Kobzova
J
, Vignerova
J
, Blaha
P
, Krejcovský
L
, Riedlová
J
. The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001
. Cent Eur J Public Health
. 2004 Sep
;12
(3
):126
–30
.22.
Allanson
JE
, Cunniff
C
, Hoyme
HE
, McGaughran
J
, Muenke
M
, Neri
G
, Elements of morphology: standard terminology for the head and face
. Am J Med Genet A
. 2009 Jan
;149A
(1
):6
–28
. .23.
Hall
BD
, Graham
JM
Jr, Cassidy
SB
, Opitz
JM
. Elements of morphology: standard terminology for the periorbital region
. Am J Med Genet A
. 2009 Jan
;149A
(1
):29
–39
. .24.
McGowan-Jordan
J
, Simons
A
, Schmid
M
. ISCN 2016, an international system for human cytogenomic nomenclature
. Cytogenet Genome Res
. 2016
;149
:1
–140
.25.
Hughes
MW
, Chuong
CM
. A mouthful of epithelial: mesenchymal interactions
. J Invest Dermatol
. 2003 Dec
;121
(6
):vii
–viii
. .26.
Berkovitz
BKB
, Holland
GR
, Moxham
BJ
. Oral anatomy, histology and embryology
. 5th ed. Elsevier
; 2018
.27.
Sadler
TW
. Langman’s medical embryology
. 12th ed. Wolters Kluwer/Lippincott Williams and Wilkins
; 2012
.28.
Urbach
A
, Benvenisty
N
. Studying early lethality of 45, XO (Turner’s syndrome) embryos using human embryonic stem cells
. PLoS One
. 2009 Jan
;4
(1
):e4175
. .29.
Hook
EB
, Warburton
D
. Turner syndrome revisited: review of new data supports the hypothesis that all viable 45, X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss
. Hum Genet
. 2014 Jan
;133
(4
):417
–24
. .30.
Hall
H
, Hunt
P
, Hassold
T
. Meiosis and sex chromosome aneuploidy: how meiotic errors cause aneuploidy; how aneuploidy causes meiotic errors
. Curr Opin Genet Dev
. 2006 Jun
;16
(3
):323
–9
. .31.
Sybert
VP
, McCauley
E
. Turner’s syndrome
. New Engl J Med
. 2004 Dec
;351
(12
):1227
–38
. .32.
Fisher
EMC
, Beer-Romero
P
, Brown
LG
, Ridley
A
, McNeil
JA
, Lawrence
JB
, Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome
. Cell
. 1990 Dec
;63
(6
):1205
–18
. .33.
Williams
BR
, Prabhu
VR
, Hunter
KE
, Glazier
CM
, Whittaker
CA
, Housman
DE
. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells
. Science
. 2008 Oct
;322
(5902
):703
–9
. .34.
Fiot
E
, Zenaty
D
, Boizeau
P
, Haignere
J
, Dos Santos
S
, Leger
J
, X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood
. Eur J Endocrinol
. 2019 Jun
;180
(6
):397
–406
. .35.
Soucek
O
, Zapletalova
J
, Zemkova
D
, Snajderova
M
, Novotna
D
, Hirschfeldova
K
, Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius
. J Clin Endocrinol Metab
. 2013 Jul
;98
(7
):E1241
–7
. .36.
Bondy
CA
, Matura
LA
, Wooten
N
, Troendle
J
, Zinn
AR
, Bakalov
VK
, The physical phenotype of girls and women with Turner syndrome is not X-imprinted
. Hum Genet
. 2007 May
;121
(3–4
):469
–74
. .37.
Vrtel
P
, Vrtel
R
, Klaskova
E
, Vrbicka
D
, Adamova
K
, Pavlicek
J
, Haplotype analysis of the X chromosome in patients with Turner syndrome in order to verify the possible effect of imprinting on selected symptoms
. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
. 2022
;166
(1
):63
–7
. .38.
Shi
W
, Sheng
X
, Dorr
KM
, Hutton
JE
, Emerson
JI
, Davies
HA
, Cardiac proteomics reveals sex chromosome-dependent differences between males and females that arise prior to gonad formation
. Dev Cell
. 2021 Nov
;56
(21
):3019
–34.e7
. .39.
Castronovo
C
, Rossetti
R
, Rusconi
D
, Recalcati
MP
, Cacciatore
C
, Beccaria
E
, Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome
. Hum Reprod
. 2014 Feb
;29
(2
):368
–79
. .40.
Bakalov
VK
, Shawker
T
, Ceniceros
I
, Bondy
CA
. Uterine development in Turner syndrome
. J Pediatr
. 2007 Nov
;151
(5
):528
–31.e1
. .41.
Pujol-Canadell
M
, Puig
R
, Armengol
G
, Barrios
L
, Barquinero
JF
. Chromosomal aberration dynamics through the cell cycle
. DNA repair
. 2020 May
;89
:102838
. .© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
